Multi-Drug Resistance

The dream product is a series of novel narrow-spectrum antibacterial agents that are able to cure any bacterial infection without induction of drug resistance, empowered by a one hour diagnostic test.


Antimicrobial resistance threatens the effective prevention and treatment of an ever-increasing range of infections. CDC estimates that in the United States, more than two million people are sickened every year with antibiotic-resistant infections, with at least 23,000 dying as a result. There are high proportions of antibiotic resistance in bacteria that cause common infections (e.g. urinary tract infections, pneumonia, bloodstream infections) in all regions of the world. A high percentage of hospital-acquired infections are caused by highly resistant bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) or multidrug-resistant Gram-negative bacteria.

Nominations for the future insight Prize 2020

Send us your candidate nomination by December 31, 2019.

Watch the Video

Realizing the dreams for a better tomorrow.


You have accessed?, but for users from your part of the world, we originally designed the following web presence?

Let's go

Share Disclaimer

By sharing this content, you are consenting to share your data to this social media provider. More information are available in our?Privacy Statement.?